立方制药：盐酸丙美卡因化学原料药上市申请获批准

Core Viewpoint - The company has received approval from the National Medical Products Administration for the marketing application of Procaine Hydrochloride, a potent ester local anesthetic [1] Group 1: Company Information - The company, Lifan Pharmaceutical (003020.SZ), announced the receipt of the approval notification for Procaine Hydrochloride [1] - Procaine Hydrochloride is primarily used in ophthalmology for surface anesthesia, indicating its application in medical settings [1] Group 2: Industry Context - Procaine Hydrochloride is classified as a fast-acting local anesthetic, which highlights its significance in the pharmaceutical industry for pain management [1]